<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a number of large-scale studies, intensive therapy regimens have improved glycemic control while reducing the microvascular complications of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, insulin use has been associated with <z:mp ids='MP_0005456'>weight gain</z:mp>, thereby hampering patient compliance with intensive insulin therapy </plain></SENT>
<SENT sid="2" pm="."><plain>As the prevalence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001513'>obesity</z:hpo> continues to increase worldwide, health care providers must incorporate the management of <z:mp ids='MP_0005456'>weight gain</z:mp> in therapeutic strategies that promote glycemic control </plain></SENT>
<SENT sid="3" pm="."><plain>The central component in any such strategy is a tailored program of medical nutrition therapy (MNT), which includes a healthy diet, physical activity, and education </plain></SENT>
<SENT sid="4" pm="."><plain>This article reviews several dietary options within a MNT program, including the uses of liquid meal replacements, low-glycemic index carbohydrates, and foods rich in <z:chebi fb="0" ids="25413">monounsaturated fatty acids</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>It also provides several practice recommendations to encourage compliance in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> who wish to manage their weight while receiving insulin therapy </plain></SENT>
</text></document>